Pivotal moment as Nanoco completes first commercial production order

Nanoco Group has completed its first ever commercial production order.

The Runcorn tech company, which develops materials used in the manufacture of monitors and TV screens and technologies for medical imaging and the early diagnosis of cancer, has made two shipments of two different first generation materials for use in infra-red sensing applications in electronic devices.

As previously announced, the board’s expectations were for a first commercial production order prior to the end of 2023 and that the first use of the group’s materials would be for low volume applications during fiscal year 2024 and 2025. Today’s announcement is in line with these expectations and supports the 2024 revenue guidance given in the group’s preliminary results published on October 17, 2023.

Nanoco Group PLC (LON:NANO) leads the world in the research, development and large-scale manufacture of heavy metal-free nanomaterials for use in displays, lighting, vertical farming, solar energy and bio-imaging.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Nanoco Group PLC

More articles like this

Nanoco Group PLC

Quantum Dots could revolutionise your portfolio

Unlock the potential of quantum dots – microscopic particles revolutionizing industries with vibrant displays, efficient sensors, and advanced medical tools. Experience the economic opportunities with Nanoco Group PLC.

Nanoco Group PLC

QDs: Harnessing Quantum Confinement

Explore the groundbreaking research on colloidal quantum dots and their ability to control photochemical reactions through quantum coherence.

Nanoco Group PLC

The promise of Quantum Dots

Quantum dots (QDs) represent a significant advancement in nanotechnology, finding applications across diverse fields. In bioimaging, their small size enables them to access almost any part of the body, making them ideal for tasks like medical